AGREEMENT TO ASSIGN PATENT APPLICATIONSPatent Applications • June 22nd, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • New York
WHEREAS, the Parties have entered into a RESEARCH COLLABORATION AND LICENSE AGREEMENT dated as of June 16, 2012 as amended by Agreement on addition of Additional Collaboration Program, dated 16th September 2013 (“Collaboration Agreement”);
DATED 16 JUNE 2012 RESEARCH COLLABORATION AND LICENSE AGREEMENTResearch Collaboration and License Agreement • June 22nd, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations • New York
[*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
LEASELease • June 22nd, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations
This Lease (this “Lease”) is dated as of September 30, 2013, between BERRUETA FAMILY PARTNERSHIP, a California limited partnership (“Landlord”), and PROTAGONIST THERAPEUTICS, INC., a Delaware corporation (“Tenant”).
THIRD AMENDMENT TO LEASELease • June 22nd, 2016 • Protagonist Therapeutics, Inc • Pharmaceutical preparations
THIS THIRD AMENDMENT TO LEASE (this “Amendment”) is dated as of August 11, 2015 (the “Effective Date”), by and between Berrueta Family L.P., a California limited partnership (“Landlord”) and Protagonist Therapeutics, Inc., a Delaware corporation (“Tenant”), with reference to the following facts and objectives:
